Oral delivery of purified lipoprotein OspA protects mice from systemic infection with Borrelia burgdorferi

Vaccine

Volumn 15, Issue 6-7, 1997, Pages 739-746

  Luke, Catherine J ^a,c   Huebner, Robert C ^b   Kasmiersky, Valerie ^a   Barbour, Alan G ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b Pasteur Merieux Connaught   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Borrelia burgdorferi; oral vaccination; OspA

Indexed keywords

IMMUNOGLOBULIN A; LIPOPROTEIN; OUTER MEMBRANE PROTEIN; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BORRELIA BURGDORFERI; BORRELIA INFECTION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOASSAY; IMMUNOBLOTTING; LYME DISEASE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030917704     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(97)00219-3     Document Type: Article

References (47)

1. Barbour, A.G., Tessier, S.L. and Todd, W.J. Lyme disease spirochetes and ixodid ticks share a common surface antigenic determinant defined by a monoclonal antibody. Infect. Immun. 1983, 41, 795-804
2. Bergstrom, S., Bundoc, V.G. and Barbour, A.G. Molecular analysis of linear plasmid-encoded major surface proteins, OspA and OspB, of the Lyme disease spirochaete Borrelia burgdorferi. Molec. Microbiol. 1989, 3, 479-486
3. Brandt, M.E., Riley, B.S., Radolf, J.D. and Norgard, M.V. Immunogenic integral membrane proteins of Borrelia burgdorferi are lipoproteins. Infect. Immun. 1990, 58, 983-991
4. Belisle, J.T., Brandt, M.E., Radolf, J.D. and Norgard, M.V. Fatty acids of Treponema pallidum and Borrelia burgdorferi lipoproteins. Bacteriology 1994, 176, 2151-2157
5. Erdile, L.F., Brandt, M., Warakomski, D.J. et al. Role of attached lipid in immunogenicity of Borrelia burgdorferi OspA. Infect. Immun. 1993, 61, 81-90
6. Dunn, J.J., Lade, B.N. and Barbour, A.G. Outer surface protein A (OspA) from the Lyme disease spirochete, Borrelia burgdorferi. high level expression and purification of a soluble recombinant form of OspA. Protein Expression Purif. 1990, 1, 159-168
7. Li, H. and Lawson, C.L. Crystallization and preliminary X-ray analysis of Borrelia burgdorferi outer surface protein A (OspA) complexed with a murine monoclonal antibody Fab fragment. J. Struct. Biol. 1995, 115, 335-337
8. Weis, J.J., Ma, Y. and Erdile, L.F. Biological activities of native and recombinant Borrelia burgdorferi outer surface protein A: dependence on lipid modification. Infect. Immun. 1994, 62, 4632-4636
9. Radolf, J.D., Arndt, L.L., Akins, D.R. et al. Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides activate monocytes/macrophages. J. Immunol. 1995, 154, 2866-2877
10. Ma, Y. and Weis, J.J. Borrelia burgdorferi outer surface lipoproteins OspA and OspB possess B-cell mitogenic and cytokine-stimulatory properties. Infect. Immun. 1993, 61, 3843-3853
11. de Silva, A.M., Telford III, S.R., Brunet, L.R., Barthold, S.W. and Fikrig, E. Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine. J. Exp. Med. 1996, 183, 271-275
12. Golde, W.T., Kappel, K.J., Dequesne, G. et al. Tick transmission of Borrelia burgdorferi to inbred strains of mice induces an antibody response to P39 but not to outer surface protein A. Infect. Immun. 1994, 62, 2625-2627
13. Kalish, R.A., Leong, J.M. and Steere, A.C. Early and late antibody responses to full-length and truncated constructs of outer surface protein A of Borrelia burgdorferi in Lyme disease. Infect. Immun. 1995, 63, 2228-2235
14. Schwan, T.G., Piesman, J., Golde, W.T., Dolan, M.C. and Rosa, P.A. Induction of an outer surface protein on Borrelia burgdorferi during tick feeding. Proc. Natl Acad. Sci. USA 1995, 92, 2909-2913
15. Fikrig, E., Telford III, S.R., Barthold, S.W., Kantor, F.S., Spielman, A. and Flavell, R.A. Elimination of Borrelia burgdorferi from vector ticks feeding on OspA-immunized mice. Proc. Natl Acad. Sci. USA 1992, 89, 5418-5421
16. Fikrig, E., Barthold, S.W., Kantor, F.S. and Flavell, R.A. Protection of mice against the Lyme disease agent by immunizing with recombinant OspA. Science 1990, 250, 553-556
17. Fikrig, E., Barthold, S.M., Kantor, F.S. and Flavell, R.A. Long-term protection of mice from Lyme disease by vaccination with OspA. Infect. Immun. 1992, 60, 773-777
18. Keller, D., Koster, F.T., Marks, D.H., Hosbach, P., Erdile, L.F. and Mays, J.P. Safety and immunogenicity of a recombinant outer surface protein A Lyme vaccine. J. Am. Med. Assoc. 1994, 271, 1764-1768
19. Fikrig, E., Barthold, S.W., Kantor, F.S. and Flavell, R.A. Protection of mice from Lyme borreliosis by oral vaccination with Escherichia coli expressing OspA. J. Infect. Dis. 1991, 164, 1224-1227
20. Dunne, M., Al-Ramadi, B.K., Barthold, S.W., Flavell, R.A. and Fikrig, E. Oral vaccination with an attenuated Salmonella typhimurium strain expressing Borrelia burgdorferi OspA prevents murine Lyme borreliosis. Infect. Immun. 1995, 63, 1611-1614
21. Langermann, S., Palaszynski, S., Sadziene, A., Stover, C.K. and Koenig, S. Systemic and mucosal immunity induced by BCG vector expressing outer-surface protein A of Borrelia burgdorferi. Nature (London) 1994, 372, 552-555
22. Mowat, A.M. The regulation of immune responses to dietary protein antigens. Immunol. Today 1988, 8, 93-98
23. Nicklin, S. and Miller, K. Local and systemic immune responses to intestinally presented antigen. Int. Archs Allergy appl. Immun. 1983, 72, 87-90
24. Norris, S.J., Carter, C.J., Howell, J.K. and Barbour, A.G. Low-passage-associated proteins of Borrelia burgdorferi B31: characterization and molecular cloning of OspD, a surface-exposed, plasmid-encoded lipoprotein. Infect. Immun. 1992, 60, 4662-4672
25. Probert, W.S. and LeFebvre, R.B. Protection of C3H/HeN mice from challenge with Borrelia burgdorferi through active immunization with OspA, OspB, OspC, but not with OspD or the 83-kilodalton antigen. Infect. Immun. 1994, 62, 1920-1926
26. Wilske, B., Preac-Mursic, V., Schierz, G., Kuhbeck, R., Barbour, A.G. and Kramer, M. Antigenic variability of Borrelia burgdorferi. Ann. N.Y. Acad. Sci. 1988, 539, 126-143
27. Schwan, T.G., Burgdorfer, W., Schrumpf, M.E. and Karstens, R.H. The urinary bladder, a consistent source of Borrelia burgdorferi in experimentally infected white-footed mice (Peromyscus leucopus). Clin. Microbiol. 1988, 26, 893-895
28. Barbour, G. Isolation and cultivation of Lyme disease spirochetes. Yale J. Biol. Med. 1984, 57, 521-525
29. Sadziene, A., Thomas, D.D. and Barbour, A.C. Borrelia burgdorferi mutant lacking Osp: biological and immunological characterization. Infect. Immun. 1995, 63, 1573-1580
30. Sadziene, A., Rosa, P.A., Thompson, P.A., Hogan, D.M. and Barbour, A.G. Antibody-resistant mutants of Borrelia burgdorferi: in vitro selection and characterization. J. Exp. Med. 1992, 176, 799-809
31. Barbour, A.G. Immunochemical analysis of Lyme disease spirochaetes. Yale J. Biol. Med. 1984, 57, 581-586
32. Sadziene, A., Thompson, P.A. and Barbour, A.G. In vitro inhibition of Borrelia burgdorferi growth by antibodies. J. Infect. Dis. 1993, 167, 165172
33. Barbour, A.G., Tessier, S.L. and Stoenner, H. Variable major proteins of Borrelia hermsii. J. Exp. Med. 1982, 156, 1312-1324
34. Sadziene, A., Thompson, P.A. and Barbour, A.G. A flagella-less mutant of Borrelia burgdorferi as a live attenuated vaccine in the murine model of Lyme disease. J. Infect Dis. 1996, 173, 1184-1193
35. Rosa, P.A., Schwan, T. and Hogan, D. Recombination between genes encoding major outer surface proteins A and B of Borrelia burgdorferi. Molec. Microbiol. 1992, 6, 3031-3040
36. Haq, T.A., Mason, H.S., Clements, J.D. and Arntzen, C.J. Oral immunization with a recombinant bacterial antigen produced in transgenic plants. Science 1995, 268, 714-716
37. Fu, C.E., Rupprecht, C.E., Dietzschold, B. et al. Oral vaccination of racoons (Procyon lotor) with baculovirus-expressed rabies virus glycoprotein. Vaccine 1993, 11, 925-928
38. Lee, C.K., Weltzin, R. and Thomas, W.D. et al. Oral immunization with recombinant Helicobacter pylori urease induces secretory IgA antibodies and protects mice from challenge with Helicobacter felis. J. Infect. Dis. 1995, 172, 161-172
39. Kagnoff, M.F. Oral tolerance. Monographs in Allergy 1988, 24, 222-226
40. Ermark, T.H., Dougherty, E.P., Bhagat, H.R., Kabok, Z. and Pappo, J. Uptake and transport of copolymer biodegradable microspheres by rabbit Peyer's patch M cells. Cell Tissue Res. 1995, 279, 433-436
41. O'Hagan, D.T., Palin, K., Davis, S.S., Artursson, P. and Sjoholm, I. Microparticles as potentially orally active immunological adjuvants. Vaccine 1989, 7, 421-424
42. Mengel, J., Cardillo, F., Aroeira, L.S., Williams, O., Russo, M. and Vaz, N.M. Anti-γδ T cell antibody blocks the induction and maintenance of oral tolerance to ovalbumin in mice. Immunol. Lett. 1995, 48, 97-102
43. 8+ T cells. Immunol. Lett. 1995, 45, 137-142
44. Nardelli, B., Haser, P.B. and Tam, J.P. Oral administration of an antigenic synthetic lipopeptide (MAP-P3C) evokes salivary anti-bodies and systemic humoral and cellular responses. Vaccine 1994, 12, 1335-1339
45. Werner, G.H., Floc'h, F., Migliore-Samour, D. and Jolies, P. Immunomodulating peptides. Experientia 1986, 42, 521-531
46. Martinon, F., Gras-Masse, H., Boutillon, C. et al. Immunization of mice with lipopeptides bypasses the prerequisite for adjuvant. J. Immunol. 1992, 149, 3416-3422
47. Akins, D.R., Purcell, B.K., Mitra, M.M., Norgard, M.V. and Radolf, J.D. Lipid modification of the 17-kilodalton membrane immunogen of Treponema pallidum determines macrophage activation as well as amphiphilicity. Infect. Immun. 1993, 61, 1202-1210